文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

作者信息

McDonagh Theresa A, Metra Marco, Adamo Marianna, Gardner Roy S, Baumbach Andreas, Böhm Michael, Burri Haran, Butler Javed, Čelutkienė Jelena, Chioncel Ovidiu, Cleland John G F, Coats Andrew J S, Crespo-Leiro Maria G, Farmakis Dimitrios, Gilard Martine, Heymans Stephane, Hoes Arno W, Jaarsma Tiny, Jankowska Ewa A, Lainscak Mitja, Lam Carolyn S P, Lyon Alexander R, McMurray John J V, Mebazaa Alexandre, Mindham Richard, Muneretto Claudio, Francesco Piepoli Massimo, Price Susanna, Rosano Giuseppe M C, Ruschitzka Frank, Kathrine Skibelund Anne

出版信息

Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.

DOI:10.1093/eurheartj/ehab368
PMID:34447992
Abstract
摘要

相似文献

[1]
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

Eur Heart J. 2021-9-21

[2]
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Eur J Heart Fail. 2016-8

[3]
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Eur Heart J. 2016-7-14

[4]
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.

Eur J Heart Fail. 2022-1

[5]
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

Eur Heart J. 2023-10-1

[6]
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Eur Heart J. 2012-7

[7]
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Europace. 2010-11

[8]
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Eur J Heart Fail. 2010-11

[9]
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Eur Heart J. 2010-11

[10]
Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.

Rev Esp Cardiol (Engl Ed). 2016-12

引用本文的文献

[1]
β-blocker and clinical outcomes in patients after myocardial infarction: a systematic review and meta-analysis.

Eur J Clin Pharmacol. 2025-9-9

[2]
Long-term effect of transcatheter mitral valve edge-to-edge repair on left ventricular function and mitral regurgitation severity: a single-center experience.

Egypt Heart J. 2025-9-8

[3]
Demographics and clinical outcomes of patients with acute heart failure : The Acute Heart Failure Registry from the Clinic Ottakring (AHF-COR Registry).

Wien Klin Wochenschr. 2025-9-8

[4]
Polypill in heart failure: a pathway to simplified treatment and improved adherence and outcomes.

Heart Fail Rev. 2025-9-6

[5]
Breaking new ground in heart failure management: novel therapies and future frontiers.

Front Cardiovasc Med. 2025-8-20

[6]
Native T1 adds independent value for cardiovascular risk assessment beyond global longitudinal strain in an all-comers real-world clinical patient population.

Eur Heart J Open. 2025-8-20

[7]
Out-of-Office Blood Pressure Measurements in Patients with Heart Failure Registry Study (OOBPM-HF study) in China: study protocol, rationale and design.

BMJ Open. 2025-9-4

[8]
Cardiac resynchronization therapy in cancer patients with chemotherapy-induced cardiomyopathy: a mini review.

Heart Fail Rev. 2025-9-4

[9]
Prognostic impact of excessive mitochondrial fission in patients with heart failure and evaluation of mitochondrial dynamics-related miRNAs in heart failure.

Hypertens Res. 2025-9-3

[10]
Revisiting Transvenous Phrenic Nerve Stimulation in Central Sleep Apnoea and Heart Failure: Emerging Innovations in Clinical Trials Analysis.

Card Fail Rev. 2025-8-20

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索